T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer

T‐cell immunoglobulin mucin 3 (TIM3) contributes to immune suppression during progression of many cancers, but the precise role of TIM3 in head and neck squamous cell carcinoma (HNSCC) is not clearly understood. In this study, we report that TIM3 expression was significantly up‐regulated in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jian‐Feng, Ma, Si‐Rui, Mao, Liang, Bu, Lin‐Lin, Yu, Guang‐Tao, Li, Yi‐Cun, Huang, Cong‐Fa, Deng, Wei‐Wei, Kulkarni, Ashok B., Zhang, Wen‐Feng, Sun, Zhi‐Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527458/
https://www.ncbi.nlm.nih.gov/pubmed/28102051
http://dx.doi.org/10.1002/1878-0261.12029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527458/
https://www.ncbi.nlm.nih.gov/pubmed/28102051
http://dx.doi.org/10.1002/1878-0261.12029

Ejemplares similares